Background

Spinal substantia gelatinosa (SG) is a site of action of administered and endogenous opioid agonists and is an important element in the system of antinociception. However, little is known about the types of neurons serving as specific postsynaptic targets for opioid action within the SG. To study the spinal mechanisms of opioidergic analgesia, the authors compared the action of mu-opioid agonist [D-Ala, N-Me-Phe, Gly-ol]-enkephalin (DAMGO) on SG neurons with different intrinsic firing properties.

Methods

Whole cell patch clamp recordings from spinal cord slices of Wistar rats were used to study the sensitivity of SG neurons to DAMGO.

Results

Three groups of neurons with distinct distributions in SG were classified: tonic-, adapting-, and delayed-firing neurons. DAMGO at 1 microm concentration selectively hyperpolarized all tonic-firing neurons tested, whereas none of the adapting- or delayed-firing neurons were affected. The effect of DAMGO on tonic-firing neurons was due to activation of G protein-coupled inward-rectifier K conductance, which could be blocked by 500 microm Ba and 500 microm Cs but increased by 50 microm baclofen. As a functional consequence of DAMGO action, a majority of tonic-firing neurons changed their pattern of intrinsic firing from tonic to adapting.

Conclusions

It is suggested that tonic-firing neurons, presumably functioning as excitatory interneurons, are primary postsynaptic targets for administered and endogenous opioid agonists in spinal SG. Functional transition of cells in this group from tonic to adapting firing mode may represent an important mechanism facilitating opioidergic analgesia.

SUBSTANTIA gelatinosa (SG) of the spinal cord is a site of termination of most fine-caliber primary afferent fibers and is therefore involved in pain conduction.1–4However, SG also represents one of the key elements in the system of pain control. High densities of enkephalin-containing neurons and axon terminals as well as opiate binding sites found in SG indicate its role in endogenous enkephalinergic antinociception.5–8Besides, SG is a site for the analgesic action of administered exogenous opioids.9–11It was shown that enkephalins inhibit SG neurons via  a combination of presynaptic and postsynaptic mechanisms. The presynaptic effects are mediated via  both μ- and δ-opioid receptors located in axons, whereas the postsynaptic inhibition is mostly attributed to activation of μ-opioid receptors in somatodendritic domains.6,7,12,13The postsynaptic μ-opioid receptors are specifically targeted to excitatory SG interneurons,14the inhibition of which may be important for the spinal mechanisms of antinociception.

The postsynaptic action of opioid agonists on SG neurons results in a robust membrane hyperpolarization associated with an increase in K+conductance.13,15–17This conductance mediated through G protein–coupled inward-rectifier K+(GIRK) channels could be blocked by low concentrations of external Ba2+and Cs+but enhanced by the γ-aminobutyric acid type B (GABAB) receptor agonist baclofen.18,19 

There are several morphologic groups of SG neurons.20–23It was shown that the neurons of all these groups can be sensitive to the μ-opioid agonist [D-Ala2, N-Me-Phe4, Gly5-ol]-enkephalin (DAMGO),17,22implying the lack of strict correlation between cell morphology and sensitivity to the drug. In addition to morphology, SG neurons are also distinguished on the basis of their membrane properties and intrinsic firing.24–27The actions of opioids on neurons with different patterns of intrinsic firing, however, have not been compared so far. Here, we report a striking correlation between the firing pattern of rat SG neurons and their sensitivity to DAMGO. The DAMGO-induced hyperpolarization was only observed in neurons with tonic-firing pattern, which possessed a functional combination of both μ-opioid receptors and GIRK channels. In addition, it has been found that the inhibition was facilitated by a transition of most neurons from tonic to adapting firing mode. It is suggested that the tonic-firing SG neurons can function as excitatory interneurons and that their selective inhibition by opioid agonists is involved in analgesic postsynaptic effects of endogenous enkephalins and administered opioids.

Tight-seal recordings were done using 200- or 300-μm coronal slices prepared from the lumbar enlargement of the spinal cord of 2- to 7-week-old Wistar rats.28The animals were killed in accordance with the national guidelines (Direcção Geral de Veterinária, Ministério da Agricultura, Lisboa, Portugal). After anesthesia by intraperitoneal injection of Na+pentobarbital (30 mg/kg), the vertebral column was quickly cut out and immersed in ice-cold oxygenated artificial cerebrospinal fluid. The segment of the lumbar enlargement was dissected and glued to the stage of the tissue slicer. Slices were prepared and incubated for 40–60 min in oxygenated artificial cerebrospinal fluid at 33°C. For recording, the slices were transferred into a 0.7-ml chamber and continuously perfused at a rate of 8 ml/min. All recordings were done at 22°–24°C. SG (lamina II) was identified as a translucent band in the dorsal horn. Each neuron was localized during recording according to the position of the pipette tip on the video image of SG.

Artificial cerebrospinal fluid contained 115 mm NaCl, 5.6 mm KCl, 2 mm CaCl2, 1 mm MgCl2, 11 mm glucose, 1 mm NaH2PO4, and 25 mm NaHCO3(pH 7.4 when bubbled with a 95%–5% mixture of oxygen–carbon dioxide). Standard pipette solution contained 6 mm NaCl, 128 mm KCl, 2 mm MgCl2, 10 mm EGTA, and 10 mm HEPES. The pH value was adjusted to 7.3 with KOH (final [K+] was 160.5 mm). In 36 experiments, guanosine 5′-triphosphate (100 μm) and adenosine 5′-triphosphate (2 mm) were added to the pipette solution. All chemicals were purchased from Sigma-Aldrich (Sintra, Portugal). DAMGO, baclofen, and naloxone (antagonist of μ-opioid receptors) were dissolved in distilled water and stored in aliquots of 4, 1.5, and 0.125 mm, respectively, at −20°C. Fresh dilutions were made with artificial cerebrospinal fluid just before the experiment. Adenosine 5′-triphosphate and guanosine 5′-triphosphate were dissolved in internal solution at final concentrations and kept in aliquots at −20°C until the experiment.

The patch pipettes had a resistance of 3–5 MΩ after fire polishing. An EPC-9 amplifier (HEKA, Lambrecht, Germany) was used in all experiments. The effective corner frequency of the low-pass filter was 3 kHz, and traces were digitized at 10 kHz. For measurements of transient K+(KA) currents, a standard P/n protocol was used for transients and leakage subtraction. Offset and liquid junction potentials were corrected for in all experiments. In neurons subjected to detailed analysis, the series resistance was 6–20 MΩ and was compensated by 60%. Fast current clamp mode of the EPC-9 amplifier was used for voltage recording. Input resistance (RIN) of SG neurons was measured in current clamp mode using negative 500-ms current pulses of 5–10 pA.

Special precautions were taken to correctly measure the resting potential in SG neurons. In current clamp mode, most commercially available patch clamp amplifiers inject into the cell a small uncompensated current of 5–20 pA, which can vary from day to day and cannot be compensated by users in a simple way (our personal observations with several EPC7, EPC9, and Axopatch 200B [Axon Instruments, Union City, CA] amplifiers). Such a current can depolarize by tens of millivolts the cells with RINin GΩ range. Therefore, before each experiment, we measured in current clamp mode a voltage decrease on a 0.5-GΩ resistor and determined the current needed to bring it to an expected 0 mV. In all following current clamp recordings, this sustained current was applied to the neuron and was considered zero current level. Under these conditions, the resting potential measured in current clamp mode was equal to the potential at which zero absolute current was recorded in voltage clamp mode. This correction may explain, at least in part, more negative resting potential values obtained here than in other patch clamp studies of dorsal horn neurons.27,29 

All numbers in the text and figures are given as mean ± SEM; numbers in table 1are given as mean ± SD. The parameters were compared using a paired or independent Student t  test. The current study is based on recordings from 149 SG neurons.

Classification of SG Neurons

Based on several criteria, SG neurons (n = 146) were separated into three groups (fig. 1): tonic-firing neurons (TFNs), adapting-firing neurons (AFNs), and delayed-firing neurons (DFNs). Three additional neurons could not be clearly classified and therefore were not subjected to study.

Tonic-firing neurons (n = 53) were able to support firing during 500-ms depolarization induced by a sustained current injection (fig. 1, A1 ). They had a low firing threshold (−51.2 ± 1.7 mV, n = 11), and 10- to 20-pA current pulses were sufficient to evoke firing (fig. 1, A2 ). Under the voltage clamp condition, the current–voltage relations in all TFNs showed pronounced inward rectification (fig. 1, A3 ). A characteristic feature of AFNs (n = 46) was a burst-like firing of only two to six spikes at the beginning of depolarization (fig. 1, B1 ). At any stimulus intensity, AFN discharges could not continue during the whole pulse. The firing threshold of −50.7 ± 1.4 mV (n = 10) was not significantly different from that in TFNs (P > 0.75, independent Student t  test). The membrane properties of AFNs (fig. 1, B2  and B3 ) were fairly similar to those of TFNs. In both TFNs and AFNs, a KAcurrent was not seen at voltage steps from −80 to −60 mV (fig. 1, A3  and B3 , insets ).

A principal difference of DFNs (n = 47) was a presence of large KAcurrent (137.9 ± 10.5 pA at voltage step from −80 to −60 mV, n = 10; P < 0.001, independent Student t  test, for comparison with either TFN or AFN group; fig. 1, C3 , inset ), which substantially influenced the firing pattern (fig. 1, C1  and C2 ). The spike threshold in DFNs (−36.4 ± 1.6 mV, n = 10) was considerably higher than in TFNs (P < 0.001, independent Student t  test) or AFNs (P < 0.001, independent Student t  test) and was reached at stimulation as strong as 50–70 pA because a large portion of injected current was compensated by activating KAcurrent. In DFNs, the first spikes typically occurred with a considerable time delay at the end of the pulse and moved to its beginning as the stimulation increased. RINin DFNs was approximately half of that in the other cell types (P < 0.001 for TFNs and P < 0.001 for AFNs, independent Student t  tests), but a more negative resting potential (table 1; P < 0.05 for either TFN or AFN group, independent Student t  tests) was closer to K+equilibrium potential of −84 mV, indicating a presence of larger resting K+conductance. An inward rectification was less pronounced in DFNs (fig. 1, C3 ). However, there were some minor variations in discharge patterns of DFNs at strong stimulation. Some cells discharged regularly during the whole pulse (fig. 1, C1 ), whereas others belonging to this group showed interrupted bursts of even single spikes (not shown).

In all three types of neurons, membrane response to hyperpolarizing voltages consisted of dominating fast inward-rectifier current. A slow hyperpolarization-activated IH-like current carried by both K+and Na+ions24,30,31was negligible in majority of SG neurons studied here using both normal and adenosine 5′-triphosphate/guanosine 5′-triphosphate–containing (n = 36) pipette solutions.

Distribution of Neuron Types in SG

Each group of neurons had its specific distribution pattern within SG (figs. 2A and B). TFNs were relatively homogeneously distributed over the whole length of SG. Few AFNs were found in medial and intermediate region, but most of them were localized in a lateral SG, especially its ventral part. Although DFNs could be found in all SG regions, their density in the medial and lateral parts was higher. The sensitivity to DAMGO was tested for the neurons of each type located in different SG regions (indicated by crosses).

Sensitivity to DAMGO

Only one neuron per slice was tested for its sensitivity to DAMGO, and the slice was not exposed to the drug before beginning of the recording to avoid a desensitization of opioid responses.16,32 

In each of 53 TFNs tested, a 30-s application of 1 μm DAMGO evoked a robust hyperpolarization ranging from 5 to 13 mV, which was accompanied by a considerable decrease in RIN(fig. 3, A1 , and table 1; P < 0.001, paired Student t  test). Membrane currents were reversibly increased in such a way that the current–voltage curves in control and 1 μm DAMGO crossed each other at a potential close to the K+equilibrium potential (fig. 3, A2 ), indicating an activation of K+selective current. Although the DAMGO-activated hyperpolarization lasted several minutes (up to 18 min) without remarkable inactivation, most TFNs responded to the drug only once, and only some cells responded to several applications. Presence of 2 mm adenosine 5′-triphosphate and 100 μm guanosine 5′-triphosphate in the pipette solution16in 9 of 53 tested TFNs did not improve their responsiveness to repetitive DAMGO applications. The hyperpolarization in TFNs was prevented if DAMGO was applied together with 100 nm naloxone (n = 7).

Neither AFNs (n = 30) nor DFNs (n = 31) responded to 1 μm DAMGO, and their RINdid not change (figs. 3B and Cand table 1; P > 0.85 for AFNs and P > 0.8 for DFNs, paired Student t  tests). Increasing the duration of DAMGO application to 1–3 min in all AFNs and DFNs or inclusion of 2 mm adenosine 5′-triphosphate and 100 μm guanosine 5′-triphosphate to the pipette solution in 15 of 30 AFNs and 12 of 31 DFNs did not affect their sensitivity to DAMGO.

Therefore, only TFNs and not AFNs or DFNs were hyperpolarized by DAMGO, which activated K+-selective conductance. The sensitivity of a neuron to DAMGO depended on its type rather than its location within the SG (fig. 2B).

Effects of Ba2+, Cs+, and Baclofen on Membrane Conductance

In experiments shown in figure 4, the effects of Ba2+, Cs+, and baclofen were studied. In seven TFNs, membrane currents were first activated by 1 μm DAMGO, and then 500 μm Ba2+was added. In all these neurons, Ba2+blocked the DAMGO-activated current (fig. 4, A1 ). Direct application of 500 μm Ba2+(without DAMGO) blocked the resting membrane conductance in all cell types in a voltage-independent manner. At −120 mV, the inward current was blocked to 38.8 ± 4.3% in TFNs (n = 4, not shown; P < 0.01, paired Student t  test), 32.4 ± 3.8% in AFNs (n = 8; fig. 4B1; P < 0.001, paired Student t  test), and 30.9 ± 3.1% in DFNs (n = 11; fig. 4, C1 ; P < 0.001, paired Student t  test). Application of 500 μm Cs+also blocked the resting K+conductance in all groups of neurons with stronger effects seen at more negative potentials (fig. 4, A2 , B2 , and C2 ). At −120 mV, an inward current was suppressed to 42.0 ± 3.9% in TFNs (n = 6; P < 0.001, paired Student t  test), 43.9 ± 5.4% in AFNs (n = 8; P < 0.001, paired Student t  test), and 30.4 ± 3.4% in DFNs (n = 5; P < 0.001, paired Student t  test). All tested TFNs (n = 21), AFNs (n = 12), and DFNs (n = 12) responded to the GABABreceptor agonist baclofen (table 1), which, similar to DAMGO, was applied to one neuron per slice. In all three groups, 50 μm baclofen reversibly induced K+current (fig. 4, A3 , B3 , and C3 ). At −120 mV, the baclofen-induced current was −90.7 ± 7.1 pA in TFNs (n = 21), −73.4 ± 10.1 pA in AFNs (n = 12), and −72.9 ± 7.1 pA in DFNs (n = 12). In contrast to DAMGO, all neurons responded to several applications of baclofen. Therefore, all groups of SG neurons possessed GIRK conductance, which could be blocked by Ba2+and Cs+but activated by baclofen via  the GABABreceptor pathway.

Modification of Discharge Pattern in TFNs by DAMGO

To study the functional consequences of postsynaptic effect of opioids, the firing patterns before and after 30-s application of 1 μm DAMGO were compared in all 53 TFNs. In 44 of them (83%), the DAMGO application reversibly induced a spike frequency adaptation in such a way that the neurons were not able to support tonic firing at any stimulation strength (fig. 5A). In addition, much stronger current injection was needed to reach the firing threshold of the first spike (fig. 5A). The discharge pattern modified by DAMGO was not improved when the membrane potential was returned to −70 mV by injecting persistent current through the recording pipette (fig. 5A, 5 min after DAMGO application). In the other 9 TFNs (17%), the tonic discharge pattern remained after DAMGO application. However, the firing characteristic constructed for those 9 TFNs was considerably shifted to the right (fig. 5B).

The current results have shown that the μ-opioid agonist DAMGO selectively inhibits TFNs in SG, whereas it had no effect on AFNs and DFNs. Our finding implies that TFNs, which receive direct inputs from Aδ- and C-type afferents,27represent a primary postsynaptic target for both administered opioids and endogenous enkephalins in the spinal cord. Cell classification on the basis of firing patterns was important for this study. Our data support several patch clamp investigations showing that SG is formed by neurons with diverse intrinsic firing properties23,27,33,34but conflict with Ruscheweyh and Sandkuhler,29who have found only adapting discharge patterns in neurons from rat lamina II (SG). Our classification is also similar to those suggested on the basis of recordings with a sharp electrode.25,26However, it cannot be excluded that some TFNs from the current study would appear as AFNs if recorded with a sharp electrode introducing larger somatic shunt.

Each group of neurons had its specific distribution pattern within SG. The intermediate SG was dominated by TFNs, the medial region contained both TFNs and DFNs, and the lateral zone contained all three types of cells with a high percentage of AFNs. This is in good agreement with Melnick et al. ,23who showed that in parasagittal spinal cord slices, including mostly the intermediate region of SG, TFNs represent 70% of the total neuronal population. The sensitivity of a given neuron to DAMGO depended on its firing properties rather than its location within the SG. Therefore, our results suggest that the percentage of neurons responding to opioids might vary along the medial–lateral axis of SG, being highest in the intermediate zone.

Agonists binding to μ-opioid receptors hyperpolarize membrane through the activation of GIRK (also known as Kir3) channels functioning as effectors.19,35,36It seems that all three types of SG neurons possess GIRK conductance, which could be blocked by Ba2+and Cs+as well as activated by baclofen via  the GABABreceptor pathway.18Selective inhibition of TFNs by DAMGO could therefore be explained by a specific targeting of postsynaptic μ-opioid receptors to TFNs rather than AFNs and DFNs. Alternatively, it is possible that AFNs and DFNs also express μ-opioid receptors but that the G protein coupling them to GIRK channels is not present. Because the majority of SG neurons expressing μ-opioid receptors do not contain GABA or glycine and therefore are excitatory interneurons,14we suggest that TFNs can function as excitatory interneurons. The intrinsic firing properties would allow them to convert stronger synaptic inputs into higher discharge frequencies in a broad range of synaptic stimulation.

The current results show that the mechanism of postsynaptic action of opioids on SG neurons is more complex and effective than it was assumed so far. Membrane hyperpolarization due to activation of GIRK conductance resulted in increased stimulation intensity needed to reach the firing threshold. In addition, most TFNs showed a transition from tonic to adapting firing mode. Therefore, the input–output characteristics of the neurons were modified in such a way that stronger synaptic input could no longer be converted into increasing numbers of generated spikes. It should be also noted that the opioid-induced plasticity of firing behavior reported here can be a complex phenomenon, which, in addition to modulation of GIRK channels,37may also involve G protein–dependent regulation of some other ion channel systems.38–40 

DAMGO-sensitive interneurons from SG send some of their axons to lamina I and V,22where most projection neurons that target supraspinal regions are located.41,42Therefore, μ-opioid agonists can inhibit SG neurons that relay primary nociceptive afferent inputs to ascending projection neurons. Suppression of excitatory interneurons with a tonic-firing pattern by enkephalins may be an important mechanism of endogenous pain control because μ-opioid receptor–expressing dorsal horn neurons were shown to be located in close proximity to enkephalinergic terminals.7,43Under physiologic conditions, they may be involved in an endogenous, i.e. , stress-induced, analgesia.

Furthermore, TFNs possessing μ-opioid receptors are likely to participate in analgesic effects of administered opioids. High sensitivity of TFNs to μ-opioid agonist implies their involvement in analgesic effects of spinal, epidural, and systemic opioids, like morphine.9–11,44At low doses, opioids do not block voltage-gated Na+and K+channels,45–47and therefore, their specific action via  opioid receptors in tonic-firing spinal sensory neurons may contribute to profound and prolonged relief of pain with virtually no motor blockade.

The authors thank Helena Pereira (Technician, Departamento de Neurobiologia Básica e Clínica, Instituto de Biologia Molecular e Celular, Porto, Portugal) for technical assistance.

1.
Rethelyi M: Preterminal and terminal axon arborizations in the substantia gelatinosa of cat’s spinal cord. J Comp Neurol 1977; 172:511–21
2.
Light AR, Perl ER: Spinal termination of functionally identified primary afferent neurons with slowly conducting myelinated fibers. J Comp Neurol 1979; 186:133–50
3.
Sugiura Y, Lee CL, Perl ER: Central projections of identified, unmyelinated (C) afferent fibers innervating mammalian skin. Science 1986; 234:358–61
4.
Cervero F: Dorsal horn neurons and their sensory inputs, Spinal Afferent Processing. Edited by Yaksh TL. New York, Plenum Press, 1987, pp 197–216Yaksh TL
New York
,
Plenum Press
5.
Ribeiro-da-Silva A, Pioro EP, Cuello AC: Substance P- and enkephalin-like immunoreactivities are colocalized in certain neurons of the substantia gelatinosa of the rat spinal cord: An ultrastructural double-labeling study. J Neurosci 1991; 11:1068–80
6.
Arvidson U, Dado RJ, Riedl M, Lee J-H, Law P-Y, Loh HH, Elde R, Wessendorf MW: δ-Opioid receptor immunoreactivity: Distribution in brainstem and spinal cord, and relationship to biogenic amines and enkephalin. J Neurosci 1995; 15:1215–35
7.
Arvidson U, Riedl M, Chakrabarti S, Lee J-H, Nakano AH, Dado RJ, Loh HH, Law P-Y, Wessendorf MW, Elde R: Distribution and targeting of a μ-opioid receptor (MOR1) in brain and spinal cord. J Neurosci 1995; 15:3328–41
8.
Merchenthaler I, Maderdrut JL, Altschuler RA, Petrusz P: Immunocytochemical localization of proenkephalin-derived peptides in the central nervous system of the rat. Neurosci 1986; 17:325–48
9.
Duggan AW, Hall JG, Headley PM: Suppression of transmission of nociceptive impulses by morphine: Selective effects of morphine administered in the region of the substantia gelatinosa. Br J Pharmacol 1977; 61:65–76
10.
Johnston SM, Duggan AW: Evidence that opiate receptors of the substantia gelatinosa contribute to the depression, by intravenous morphine, of the spinal transmission of impulses in unmyelinated afferents. Brain Res 1981; 207:223–8
11.
Eltzschig HK, Lieberman ES, Camann WR: Regional anesthesia and analgesia for labor and delivery. N Engl J Med 2003; 348:319–32
12.
Dado RJ, Law PY, Loh HH, Elde R: Immunofluorescent identification of a delta (δ)-opioid receptor on primary afferent nerve terminals. Neuroreport 1993; 5:341–4
13.
Grudt TJ, Williams JT: μ-Opioid agonists inhibit spinal trigeminal substantia gelatinosa neurons in guinea pig and rat. J Neurosci 1994; 14:1646–54
14.
Kemp T, Spike RC, Watt C, Todd AJ: The μ-opioid receptor (MOR1) is mainly restricted to neurons that do not contain GABA or glycine in the superficial dorsal horn of the rat spinal cord. Neurosci 1996; 75:1231–8
15.
Yoshimura M, North RA: Substantia gelatinosa neurones hyperpolarized in vitro by enkephalin. Nature 1983; 305:529–30
16.
Schneider SP, Eckert WA, Light AR: Opioid-activated postsynaptic, inward rectifying potassium currents in whole cell recordings in substantia gelatinosa neurons. J Neurophysiol 1998; 80:2954–62
17.
Light AR, Willcockson HH: Spinal laminae I-II neurons in rat recorded in vivo in whole cell, tight seal configuration: Properties and opioid responses. J Neurophysiol 1999; 82:3316–26
18.
Sodickson DL, Bean B: GABABreceptor-activated inwardly rectifying potassium current in dissociated hippocampal CA3 neurons. J Neurosci 1996; 16:6374–85
19.
Svoboda KR, Lupica CR: Opioid inhibition of hippocampal interneurons via modulation of potassium and hyperpolarization-activated cation (Ih) currents. J Neurosci 1998; 18:7084–98
20.
Gobel S: Golgi studies of the neurons in layer II of the dorsal horn of the medulla (trigeminal nucleus caudalis). J Comp Neurol 1978; 180:395–414
21.
Todd AJ: Electron microscope study of Golgi-stained cell in lamina II of the rat spinal dorsal horn. J Comp Neurol 1988; 275:145–57
22.
Eckert WA, McNaughton KK, Light AR: Morphology and axonal arborization of rat spinal inner lamina II neurons hyperpolarized by μ-opioid-selective agonists. J Comp Neurol 2003; 458:240–56
23.
Melnick IV, Santos SFA, Szokol K, Szucs P, Safronov BV: Ionic basis of tonic firing in spinal substantia gelatinosa neurons of rat. J Neurophysiol 2004; 91:646–55
24.
Yoshimura M, Jessel TM: Membrane properties of rat substantia gelatinosa neurons in vitro. J Neurophysiol 1989; 62:109–18
25.
Thomson AM, West DC, Headley PM: Membrane characteristics and synaptic responsiveness of superficial dorsal horn neurons in a slice preparation of adult rat spinal cord. Eur J Neurosci 1989; 1:479–88
26.
Lopez-Garcia JA, King AE: Membrane properties of physiologically classified rat dorsal horn neurons in vitro: Correlation with cutaneous sensory afferent input. Eur J Neurosci 1994; 6:998–1007
27.
Grudt TJ, Perl ER: Correlations between neuronal morphology and electrophysiological features in the rodent superficial dorsal horn. J Physiol 2002; 540:189–207
28.
Edwards FA, Konnerth A, Sakmann B, Takahashi T: A thin slice preparation for patch clamp recordings from neurones of the mammalian central nervous system. Pflugers Arch 1989; 414:600–12
29.
Ruscheweyh R, Sandkuhler J: Lamina-specific membrane and discharge properties of rat spinal dorsal horn neurones in vitro. J Physiol 2002; 541:231–44
30.
Mayer ML, Westbrook GL: A voltage-clamp analysis of inward (anomalous) rectification in mouse spinal sensory ganglion neurones. J Physiol 1983; 340:19–45
31.
Pape H-C: Queer current and pacemaker: The hyperpolarization-activated cation current in neurons. Annu Rev Physiol 1996; 58:299–327
32.
Blanchet C, Luscher C: Desensitization of mu-opioid receptor-evoked potassium currents: Initiation at the receptor, expression at the effector. Proc Natl Acad Sci U S A 2002; 99:4674–9
33.
Lu Y, Perl ER: A specific inhibitory pathway between substantia gelatinosa neurons receiving direct C-fiber input. J Neurosci 2003; 23:8752–8
34.
Hu H-J, Gereau RW: ERK integrates PKA and PKC signaling in superficial dorsal horn neurons: II. Modulation of neuronal excitability. J Neurophysiol 2003; 90:1680–8
35.
Wimpey TL, Chavkin C: Opioids activate both an inward rectifier and a novel voltage-gated potassium conductance in the hippocampal formation. Neuron 1991; 6:281–9
36.
Ikeda K, Kobayashi T, Yano R, Sora I, Niki H: Molecular mechanisms of analgesia induced by opioids and ethanol: Is the GIRK channel one of the keys? Neurosci Res 2002; 44:121–31
37.
Derjean D, Bertrand S, Masson GL, Landry M, Morisset V, Nagy F: Dynamic balance of metabotropic inputs causes dorsal horn neurons to switch functional states. Nature Neurosci 2003; 6:274–81
38.
Ma JY, Li M, Catterall WA, Scheuer T: Modulation of brain Na+channels by a G-protein-coupled pathway. Proc Natl Acad Sci U S A 1994; 91:12351–5
39.
Müller W, Hallermann S, Swandulla D: Opioidergic modulation of voltage-activated K+currents in magnocellular neurons of the supraoptic nucleus in rat. J Neurophysiol 1999; 81:1617–25
40.
Law PY, Wong YH, Loh HH: Molecular mechanisms and regulation of opioid receptor signaling. Annu Rev Pharmacol Toxicol 2000; 40:389–430
41.
Trevino DL, Coulter JD, Willis WD: Location of cells of origin of spinothalamic tract in lumbar enlargement of the monkey. J Neurophysiol 1973; 36:750–61
42.
Lima D: Anatomical basis for the dynamic processing of nociceptive input. Eur J Pain 1998; 2:195–202
43.
Song B, Marvizon JC: Peptidases prevent mu-opioid receptor internalization in dorsal horn neurons by endogenously released opioids. J Neurosci 2003; 23:1847–58
44.
Wang JK, Nauss LA, Thomas JE: Pain relief by intrathecally applied morphine in man. Anesthesiology 1979; 50:149–51
45.
Hu S, Rubly N: Effects of morphine on ionic currents in frog node of Ranvier. Eur J Pharmacol 1983; 95:185–92
46.
Bräu ME, Koch ED, Vogel W, Hempelmann G: Tonic blocking action of meperidine on Na+and K+channels in amphibian peripheral nerves. Anesthesiology 2000; 92:147–55
47.
Wolff M, Olschewski A, Vogel W, Hempelmann G: Meperidine suppresses the excitability of spinal dorsal horn neurons. Anesthesiology 2004; 100:947–55